Journal of Biochemistry Advance Access published online on March 24, 2009
Journal of Biochemistry, doi:10.1093/jb/mvp054
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accurate determination of carboxyl-terminal fragment of Presenilin 1 in various tissues from rat and cell lines
Radioisotope Research Center, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004
*To whom correspondence should be addressed: Radioisotope Research Center, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. Tel.: +81-45-787-2760 Fax: +81-45-782-1251 E-mail: smiura{at}med.yokohama-cu.ac.jp.
Received March 16, 2009; Accepted March 16, 2009
| Abstract |
|---|
Presenilin 1 (PS1) has been identified as a causative gene for the early-onset of familial Alzheimer's disease, and it is mainly localized in the endoplasmic reticulum and the Golgi membrane as a multiple membrane-spanning protein. In the cell, PS1 is proteolytically processed to a 30 kDa N-terminal fragment and a 20 kDa C-terminal fragment (CTF), both of which exist as a stable high molecular weight protein complex, together with other components of
-secretase. However, as there has been no report about the precise amount of PS1 expressed in mammalian tissues, the aim of this study was to quantitatively determine PS1-CTF amounts in various tissues such as liver, kidney, brain, and heart of rat by Western blotting using a [35S]-methionine-labeled PS1-CTF as a standard synthesized in a wheat germ cell-free protein synthesizing system. PS1-CTF contents in kidney, liver, brain, and heart were 17.0, 6.6, 6.4, and 0.2 fmol/mg protein, respectively. PS1-CTF contents were also determined in cultured cell lines such as HeLa, HEK293, and COS-1.
Key Words: Alzheimer's disease, Cell free protein synthesis, Presenilin 1, Quantitative Analysis, Western blotting